Innospec (IOSP) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
26 Mar, 2026Executive summary
Annual meeting scheduled for May 8, 2026, at The St Regis Hotel, New York City, at 10:00 a.m. EST.
Proxy materials and Form 10-K are available online for review and voting.
Shareholders can request paper or electronic copies of proxy materials at no charge.
Voting must be completed electronically by 11:59 p.m. ET on May 7, 2026.
Voting matters and shareholder proposals
Election of two directors: Elizabeth K. Arnold and Claudia P. Poccia.
Advisory approval of executive compensation (say-on-pay) is on the agenda.
Ratification of the appointment of the independent registered public accounting firm.
Board recommends voting FOR all nominees and proposals.
Board of directors and corporate governance
Board of Directors provides recommendations for all voting items.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Innospec
- Q3 sales grew 7%, with $251.9M net cash and strong segment growth.IOSP
Q3 2026 - Q4 adjusted EPS rose 53% as QGP closed and net cash reached $203.7 million.IOSP
Q4 2023 - Double-digit sales and income growth, strong cash, and plant upgrades support future gains.IOSP
Q2 2026 - Revenue up 3% to $453.2M; dividend raised 10%; new $75M buyback amid mixed segment results.IOSP
Q1 2026 - Proxy covers director elections, executive pay, auditor ratification, and strong ESG performance.IOSP
Proxy filing - Net income rebounded sharply, margins improved, and net cash reached $292.5 million.IOSP
Q4 2025 - Double-digit operating income growth, strong cash, and a 10% dividend hike despite lower sales.IOSP
Q3 2024 - Performance Chemicals and Fuel Specialties drove profit growth despite Oilfield Services weakness.IOSP
Q2 2024 - Performance Chemicals and Fuel Specialties growth offset Oilfield Services decline; net cash $289.2m.IOSP
Q4 2024